Evidence map›Paper›PMID 34994476›Full record

ArticleEMBO reports2022

Exosome-like nanoparticles from Mulberry bark prevent DSS-induced colitis via the AhR/COPS8 pathway.

Mukesh K Sriwastva, Zhong-Bin Deng, Bomei Wang, Yun Teng, Anil Kumar, Kumaran Sundaram, Jingyao Mu, Chao Lei, Gerald W Dryden, Fangyi Xu and 7 more

Abstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Antioxidants (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mukesh K Sriwastva *Department of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.ORCID 0000-0003-4370-4625
Zhong-Bin Deng *Department of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Bomei WangDepartment of Translational Oncology, Genentech, San Francisco, California, USA.
Yun TengDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Anil KumarDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Kumaran SundaramDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Jingyao MuDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Chao LeiDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Gerald W DrydenDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Fangyi XuDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Lifeng ZhangDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Jun YanDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Xiang ZhangKBRIN Bioinformatics Core, University of Louisville, Louisville, KY, USA.
Juw Won ParkKBRIN Bioinformatics Core, University of Louisville, Louisville, KY, USA.ORCID 0000-0002-4610-6893
Michael L MerchantKidney Disease Program and Clinical Proteomics Center, University of Louisville, Louisville, KY, USA.
Nejat K EgilmezDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Huang-Ge ZhangDepartment of Microbiology & Immunology, Brown Cancer Center, University of Louisville, Louisville, KY, USA.ORCID 0000-0001-9665-9202

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative IntravaginalP20GM125504 · NIGMS · UNIVERSITY OF LOUISVILLE · PI James Tristan Collins · 2018 to 2026
$24.4M
Role of oxidized linoleic acid metabolites in the pathogenesis of alcoholic liver diseaseP20GM113226 · NIGMS · UNIVERSITY OF LOUISVILLE · PI GHARE, SMITA S · 2016 to 2025
$24.1M
The Role of Nutrition in the Development/Progression of Alcohol-Induced Organ InjuryP50AA024337 · NIAAA · UNIVERSITY OF LOUISVILLE · PI SHIRISH S BARVE · 2016 to 2026
$17.9M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI J CHRISTOPHER STATES · 2020 to 2026
$10.0M
Plant exosomes non-coding RNA-mediated anti-inflammatory mechanismsR01AT008617 · NCCIH · UNIVERSITY OF LOUISVILLE · PI HUANG-GE ZHANG · 2016 to 2026
$5.7M
Mechanisms of Probiotics in Alcoholic Liver DiseaseR01AA023190 · NIAAA · UNIVERSITY OF LOUISVILLE · PI FENG, WENKE · 2015 to 2024
$3.5M
Biomarkers of Alcoholic HepatitisR01AA028436 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ARTEEL, GAVIN E, BENOS, PANAGIOTIS V · 2020 to 2024
$3.0M
Novel Biomarkers for Post-Liver Transplant NASH FibrosisR01DK130294 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ARTEEL, GAVIN E, BENOS, PANAGIOTIS V · 2022 to 2025
$2.8M
CSN8 regulation of S1P-enriched extracellular vesicles to modulate NAFLD by gut-liver axisR01DK115406 · NIDDK · UNIVERSITY OF LOUISVILLE · PI DENG, ZHONG-BIN · 2018 to 2022
$2.0M
Role of exosomes in the coordinated migration of neural crest cells and placodes and ethanol-induced teratogenesisR01AA028435 · NIAAA · UNIVERSITY OF LOUISVILLE · PI CHEN, SHAO-YU · 2020 to 2024
$1.8M
Gut extracellular vesicles promote alcohol-induced liver injury via TLR4-regulated miRNAsR21AA025724 · NIAAA · UNIVERSITY OF LOUISVILLE · PI DENG, ZHONG-BIN · 2018 to 2019
$558k
BLRD VA IK6 BX004199NCCIH NIH HHS R01 AT008617NIAAA NIH HHS P50 AA024337NIAAA NIH HHS R01 AA023190NIAAA NIH HHS R01 AA028435NIAAA NIH HHS R01 AA028436NIAAA NIH HHS R21 AA025724NIAID NIH HHS R21 AI159194NIDDK NIH HHS R01 DK115406NIDDK NIH HHS R01 DK130294NIEHS NIH HHS P30 ES030283NIGMS NIH HHS P20 GM103436NIGMS NIH HHS P20 GM113226NIGMS NIH HHS P20 GM125504
6 · The paper itself

Abstract

Bark protects the tree against environmental insults. Here, we analyzed whether this defensive strategy could be utilized to broadly enhance protection against colitis. As a proof of concept, we show that exosome-like nanoparticles (MBELNs) derived from edible mulberry bark confer protection against colitis in a mouse model by promoting heat shock protein family A (Hsp70) member 8 (HSPA8)-mediated activation of the AhR signaling pathway. Activation of this pathway in intestinal epithelial cells leads to the induction of COP9 Constitutive Photomorphogenic Homolog Subunit 8 (COPS8). Utilizing a gut epithelium-specific knockout of COPS8, we demonstrate that COPS8 acts downstream of the AhR pathway and is required for the protective effect of MBELNs by inducing an array of anti-microbial peptides. Our results indicate that MBELNs represent an undescribed mode of inter-kingdom communication in the mammalian intestine through an AhR-COPS8-mediated anti-inflammatory pathway. These data suggest that inflammatory pathways in a microbiota-enriched intestinal environment are regulated by COPS8 and that edible plant-derived ELNs may hold the potential as new agents for the prevention and treatment of gut-related inflammatory disease.

Indexed as

ColitisExosomesMorusNanoparticlesAnimalsDisease Models, AnimalMiceMice, Inbred C57BLPlant BarkAhRanti-microbial peptidesCOP9/COPS8heat shock protein family A (Hsp70) member 8inflammationMulberry bark derived exosome-like nanoparticles

Identifiers

PMID34994476
PMCPMC8892346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.